Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
321
Baillet A., Gossec L., Carmona L. et al. Points to consider for reporting, screening for and preventing
selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative
// Ann. Rheum. Dis. 2016. Vol. 75, N. 6. P. 965- 973.
Bozkurt B., Aguilar D., Deswal A. et al. Contributory risk and management of comorbidities of
hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart
failure. ascientific statement from the American Heart Association // Circulation. 2016. Vol. 134. P.
e535-e578.
Dan G., Martinez-Rubio A., Agewall S. et al. Antiarrhythmic drugs - clinical use and clinical decision
making: a consensus document from the EHRA and ESC Working Group on Cardiovascular
Pharmacology, endorsed by the HRS, APHRS and ISCP //
Europace. 2018. Vol. 5. P. 731-732.
De Hert S., Staender S., Fritsch G. et al. Pre-operative evaluation of adults undergoing elective
noncardiac surgery: updated Guideline from the European Society of Anaesthesiology // Eur. J.
Anaesthesiol. 2018. Vol. 35. P. 407-465.
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus
infection // J. Hepatol. 2017. Vol. 67. P. 370-398.
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis // J.
Hepatol. 2018. Vol. 69, N. 2. P. 406-460.
EASL Recommendations on treatment of hepatitis C 2018 // J. Hepatol. 2018.
Vol. 69, N. 2. P. 461-511.
EULAR Recommendations for the management of rheumatoid arthritis with synthetic and biological
disease-modifying antirheumatic drugs: 2016 update //
Ann. Rheum. Dis. 2017. Vol. 76, N. 6. P. 960.
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid
arthritis and other forms of inflammatory joint disorders: 2015/2016
update // Ann. Rheum. Dis. 2017. Vol. 76, N. 1. P. 17-28.
European Association of Urology. 2017 Guidelines. 1374 p.
European Association of Urology Pocket Guidelines. 2018 ed. 415 p.
European Centre for Disease Prevention and Control. Expert Opinion on Neuraminidase Inhibitors for
the Prevention and Treatment of Influenza - Review of Recent Systematic Reviews and Meta-Analyses.
Stockholm : ECDC, 2017. 43 p.
European Helicobacter pylori Study Group. The year in Helicobacter pylori 2018 //
Helicobacter. 2018. Vol. 23. P. S1.
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the
2008 British Association for Psychopharmacology Guidelines //
J. Psychopharmacol. 2015. Vol. 29, N. 5. P. 459-525.
Источник KingMed.info
322
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and
obsessive-compulsive disorder: a revision of the 2005 Guidelines from the British Association for
Psychopharmacology // J. Psychopharmacol. 2014.
Vol. 28, N. 5. P. 403-439.
Fallone C.A., Chiba N., van Zanten S.V. et al. The Toronto consensus for the treatment of Helicobacter
pylori infection in adults // Gastroenterology. 2016. Vol. 151,
N. 1. P. 51-69.e14.
Global Strategy for Asthma Management and Prevention. 2018. 155 p.
Global Strategy For The Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary
Disease. Report. 2019. 139 p.
Gomi H., Solomkin J.S., Schlossberg D. et al. Tokyo Guidelines 2018: antimicrobial therapy for acute
cholangitis and cholecystitis // J. Hepatobiliary Pancreat Sci. 2018.
Vol. 25, N. 1. P. 3-16.
Götestam S.C., Hoeltzenbein M., Tincani A. et al. The EULAR points to consider for use of antirheumatic
drugs before pregnancy, and during pregnancy and lactation //
Ann. Rheum. Dis. 2016. Vol. 75, N. 5. P. 795-810.
Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American
Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity // J. Am. Geriatr. Soc.
2012. Vol. 60, N. 10. P. 1-25.
Hepatitis C Guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating
hepatitis C virus infection // Clin. Infect. Dis. 2018. Vol. 67,
N. 10. P. 1477-1492.
KDIGO Clinical Practice Guideline for evaluation and management of CKD // Kidney Int. 2013. Suppl. 3.
P. 1-150.
Kramer H., Townsend R., Griffin K. et al. KDOQI US Commentary on the 2017 ACC/AHA Hypertension
Guideline / Am. J. Kidney Dis. 2019. Vol. 4. P. 437-458.
Malfertheiner P., Megraud F., O'Morain C.A. et al. Management of Helicobacter pylori infection - the
Maastricht V/Florence Consensus Report // Gut. 2017. Vol. 66,
N. 1. P. 6-30.
Newman C., Preiss D., Tobert J. et al. Statin safety and associated adverse events: ascientific statement
from the American Heart Association // Arterioscler. Thromb. Vasc. Biol. 2018. Oct. 12.
NHS Foundation. Medicines Management Tool for Antipsychotics. 2018. 60 p.
NICE. Multimorbidity: Clinical Assessment and Management. London, 2016.
443 p.
Niessner A., Tamargo J., Koller L. et al. Non-insulin antidiabetic pharmacotherapy in patients with
established cardiovascular disease: a position paper of the European Society of Cardiology Working
Group on Cardiovascular Pharmacotherapy // Eur. Heart J. 2018. Vol. 24. P. 2274-2281.
Источник KingMed.info
323
Page R.L., O'Bryant C.L., Cheng D. et al. Drugs that may cause or exacerbate heart failure: a scientific
statement from the American Heart Association // Circulation.
2016. Vol. 134, N. 6. P. e32-e69.
Rangaswami J, Bhalla V, Blair J EA., et al. Cardiorenal Syndrome: Classification, Pathophysiology,
Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Circulation. 2019.
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and
Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American
Heart Association // Circulation.
2016. Vol. 134. e468-e495.
Ronco C., McCullough P., Anker S.D. et al. Cardio-renal syndromes: report from the consensus
conference of the Acute Dialysis Quality Initiative // Eur. Heart J. 2010.
Vol. 31. P. 3-11.
The management of depression during pregnancy: a report from the American Psychiatric Association
and the American College of Obstetricians and Gynecologists // Gen. Hosp. Psychiatry. 2009. Vol. 31. Р.
403-413.
Статьи, книги
Белялов Ф.И. Психосоматика. 8-е изд. М. : ГЭОТАР-Медиа, 2019. 360 с. Клинические
рекомендации по кардиологии и коморбидным болезням. 9-е изд. / под ред. Ф.И.Белялова. М. :
ГЭОТАР-Медиа, 2019. 352 с.
Котляров А.А., Мосина Л.М., Чибисов С.М. и др. Антиаритмическая терапия пароксизмальных
тахикардий и экстрасистолий у больных с дисфункцией синусового узла // Клин. мед. 2012. Т. 9,
№ 20. С. 57-59.
Aaron C., Schwartz J., Hoffman E. et al. A longitudinal cohort study of aspirin use and progression of
emphysema-like lung characteristics on CT imaging // Chest. 2018.
Vol. 1. P. 41-50.
Abbott R., Whear R., Nikolaou V. et al. Tumour necrosis factor-a inhibitor therapy in chronic physical
illness: a systematic review and meta-analysis of the effect on depression and anxiety // J. Psychosom.
Res. 2015. Vol. 79, N. 3. P. 175-184.
Abutaleb N. Why we shouldd sub-divide CKD stage 3 into early (3a) and late (3b) components //
Nephrol. Dial. Transplant. 2007. Vol. 22, N. 9. P. 2728-2729.
Adams T.D., Davidson L.E., Litwin S.E. et al. Health benefits of gastric bypass
surgery after 6 years // JAMA. 2012. Vol. 308, N. 11. P. 1122-1131.
Afkarian M., Zelnick L.R., Hall Y.N. et al. Clinical manifestations of kidney disease among US adults with
diabetes, 1988-2014 // JAMA. 2016. Vol. 316, N. 6. P. 602-610.
Afolabi B.A., Novaro G.M., Szomstein S. et al. Cardiovascular complications of obesity surgery in
patients with increased preoperative cardiac risk // Surg. Obes. Relat.
Dis. 2009. Vol. 5, N. 6. P. 653-656.
Источник KingMed.info
324
Agarwal N., Jain A., Mahmoud A.N. et al. Safety and efficacy of dual versus triple antithrombotic
therapy in patients undergoing percutaneous coronary intervention // Am. J. Med. 2017. Vol. 130, N.
11. P. 1280-1289.
Agarwal V., Hans N., Messerli F.H. Effect of allopurinol on blood pressure: a systematic review and
meta-analysis // J. Clin. Hypertens. 2013. Vol. 15, N. 6.
P. 435-442.
Aguilar D., Bozkurt B., Ramasubbu K. et al. Relationship of hemoglobin A1C and mortality in heart
failure patients with diabetes // J. Am. Coll. Cardiol. 2009. Vol. 54,
N. 5. P. 422-428.
Ahimastos A.A., Walker P.J., Askew C. et al. Effect of ramipril on walking times and quality of life among
patients with peripheral artery disease and intermittent claudication: arandomized controlled trial //
JAMA. 2013. Vol. 309, N. 5. P. 453-460.
Ahmad S., Xue Z., Silverman A. et al. Complexity ofthe relation between hemoglobin A1C, diabetes
mellitus, and progression of coronary narrowing in postmenopausal
women // Am. J. Cardiol. 2013. Vol. 111, N. 6. P. 793-799.
Ahmed A., Rich M.W., Zile M. et al. Renin-angiotensin inhibition in diastolic heart
failure and chronic kidney disease // Am. J. Med. 2013. Vol. 126, N. 2. P. 150-161.
Ahmed M.I., Aban I., Lloyd S.G. et al. A randomized controlled phase IIb trial of beta1-receptor
blockade for chronic degenerative mitral regurgitation // J. Am. Coll.
Cardiol. 2012. Vol. 60, N. 9. P. 833-838.
Ahn J., Kim S., Park S. et al. Coronary microvascular dysfunction as a mechanism of angina in severe AS:
prospective adenosine-stress CMR study // J. Am. Coll. Cardiol. 2016. Vol. 67, N. 12. P. 1412-1422.
Alawami M., Wasywich C., Cicovic A., Kenedi C. A systematic review of clozapine induced
cardiomyopathy // Int. J. Cardiol. 2014. Vol. 176, N. 2. P. 315-320.
Alberts M.J. Do antiplatelet agents increase the risk of recurrent intracerebral hemorrhage? // Nat. Clin.
Pract. Neurol. 2006. Vol. 2. P. 480-481.
Alonso A., MacLehose R.F., Chen L.Y. et al. Prospective study of oral anticoagulants and risk of liver
injury in patients with atrial fibrillation // Heart. 2017. Vol. 103, N. 11.
P. 834-839.
Alqahtani F., Aljohani S., Tarabishy A. et al. Incidence and outcomes of myocardial infarction in patients
admitted with acute ischemic stroke // Stroke. 2017. Vol. 11.
P. 2931-2938.
Amandeep S.D., Gabriel H., Anita D. et al. Impact of alpha 1-adrenergic antagonist use for benign
prostatic hypertrophy on outcomes in patients with heart failure // Am.
J. Cardiol. 2009. Vol. 104, N. 2. P. 270-275.
Источник KingMed.info
325
Ambrosino P., Lupoli R., Di Minno A. et al. The risk of coronary artery disease and cerebrovascular
disease in patients with hepatitis C: a systematic review and metaanalysis // Int. J. Cardiol. 2016. Vol.
221. P. 746-754.
American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically
Ill. 3
rd
ed. / ed. J.L. Levenson. Washington, 2019. 1410 p.
An J., Shim J.H., Kim S.-O. et al. Prevalence and prediction of coronary artery disease in patients with
liver cirrhosis: aregistry-based matched case-control study // Circulation. 2014. Vol. 130. P. 1353-1362.
An T., Hao J., Sun S. et al. Efficacy of statins for osteoporosis: a systematic review and meta-analysis //
Osteoporos. Int. 2017. Vol. 28, N. 1. P. 47-57.
An Y., Wang Y., Wu S. et al. Fourth-generation quinolones in the treatment of Helicobacter pylori
infection: a meta-analysis // World J. Gastroenterol. 2018. Vol. 24, N. 29. P. 3302-3312.
Andalib S., Emamhadi M.R., Yousefzadeh-Chabok S. et al. Maternal SSRI exposure increases the risk of
autistic offspring: a meta-analysis and systematic review // Eur.
Psychiatry. 2017. Vol. 45. P. 161-166.
Andersen M.N., Olsen A.-M., Madsen J.S. et al. Levothyroxine substitution in subclinical hypothyroidism:
does it have a beneficial effect on all-cause mortality? European Congress of Endocrinology 2014.
Wrocław, Poland, 2014.
Andersson C., Lyngbak S., Nguyen C. et al. Association of clopidogrel treatment with risk of mortality
and cardiovascular events following myocardial infarction in patients with and without diabetes //
JAMA. 2012. Vol. 308, N. 9. P. 882-889.
Andersson T., Magnuson A., Bryngelsson I.L. et al. All-cause mortality in 272 186 patients hospitalized
with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study // Eur.
Heart. J. 2013. Vol. 34, N. 14. P. 1061-1067.
Andò G., Capranzano P. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with
chronic kidney disease: a systematic review and network meta-
analysis // Int. J. Cardiol. 2017. Vol. 231. P. 162-169.
Andrade J.G., Roy D., Wyse D.G. et al. ECG features associated with adverse cardiovascular outcomes in
patients with atrial fibrillation: acombined AFFIRM and AF-CHF analysis // J. Cardiovasc. Electrophysiol.
2016. Vol. 27, N. 4. P. 404-413.
Anglin R.E.S., Samaan Z., Walter S.D. et al. Vitamin D deficiency and depression in adults: systematic
review and meta-analysis // Br. J. Psychiatry. 2013. Vol. 202, N. 2.
P. 100-107.
Anker S.D., Doehner W., Rauchhaus M. et al. Uric acid and survival in chronic heart failure: validation
and application in metabolic, functional, and hemodynamic staging // Circulation. 2003. Vol. 107. P.
1991-1997.
Anselmino M., Matta M., D'Ascenzo F. et al. Catheter ablation of atrial fibrillation in patients with
diabetes mellitus: a systematic review and meta-analysis // Europace.
2015. Vol. 17. P. 1518-1525.
Источник KingMed.info
326
Anselmino M., Matta M., D'Ascenzo F. et al. Catheter ablation of atrial fibrillation in patients with left
ventricular systolic dysfunction: a systematic review and meta-analysis // Circ. Arrhythm. Electrophysiol.
2014. Vol. 7, N. 6. P. 1011-1018.
Antiopi N., Konstantinos A., Deepikshana K. et al. Hypoglycaemia is associated with increased risk of
fractures in patients with type 2 diabetes mellitus: a cohort study // Eur. J. Endocrinol. 2019. Vol. 1. P.
51-58.
Antoniou T., Gomes T., Mamdani M.M. et al. Trimethoprim-sulfamethoxazole induced hyperkalaemia in
elderly patients receiving spironolactone: nested case-control study // BMJ. 2011. Vol. 343. Article ID
d5228.
Apperley S., Park H.Y., Holmes D.T. et al. Serum bilirubin and disease progression in mild COPD //
Chest. 2015. Vol. 148. P. 169-175.
Artang R., Rome E., Nielsen J.D., Vidaillet H.J. Meta-analysis of randomized controlled trials on risk of
myocardial infarction from the use of oral direct thrombin inhibitors // Am. J. Cardiol. 2013. Vol. 112, N.
12. P. 1973-1979.
Ashton R.E., Millward-Sadler G.H., White J.E. Complications in methotrexate treatment of psoriasis with
particular reference to liver fibrosis // J. Invest. Dermatol.
1982. Vol. 79. P. 229-232.
Atasoy N., Erdogan A., Yalug I. et al. A review of liver function tests during treatment with atypical
antipsychotic drugs: a chart review study // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007. Vol.
31, N. 6. P. 1255-1260.
Ather S., Shendre A., Beasley T.M. et al. Effect of left ventricular systolic dysfunction on response to
warfarin // Am. J. Cardiol. 2016. Vol. 118, N. 2. P. 232-236.
Aung P.P., Maxwell H.G., Jepson R.G. et al. Lipid-lowering for peripheral arterial disease of the lower
limb // Cochrane Database Syst. Rev. 2007. Vol. 4.
Aziz Q., Fass R., Gyawali C.P. et al. Functional esophageal disorders //
Gastroenterology. 2016. Vol. 150. P. 1368-1379.
Azoulay L., Suissa S. Sulfonylureas and the risks of cardiovascular events and death: a methodological
meta-regression analysis of the observational studies // Diabetes
Care. 2017. Vol. 40, N. 5. P. 706.
Badheka A.O., Marzouka G.R., Rathod A.D. et al. Comparison of rate versus rhythm control in patients
with atrial fibrillation and a pacemaker // Am. J. Cardiol.
2013. Vol. 111, N. 12. P. 1759-1763.
Badheka A.O., Rathod A., Kizilbash M.A. et al. Influence of obesity on outcomes in atrial fibrillation: yet
another obesity paradox // Am. J. Med. 2010. Vol. 123, N. 7.
P. 646-651.
Badve S.V., Roberts M.A., Hawley C.M. et al. Effects of beta-adrenergic antagonists in patients with
chronic kidney disease: a systematic review and meta-analysis // J. Am.
Coll. Cardiol. 2011. Vol. 58, N. 11. P. 1152-1161.
Источник KingMed.info
327
Bailey R.D., Hart R.G., Benavente O., Pearce L.A. Recurrent brain hemorrhage is more frequent than
ischemic stroke after intracranial hemorrhage // Neurology. 2001.
Vol. 56, N. 6. P. 773-777.
Baillargeon J., Holmes H.M., Lin Y.L. et al. Concurrent use of warfarin and antibiotics and the risk of
bleeding in older adults // Am. J. Med. 2012. Vol. 125, N. 2.
P. 183-189.
Bajaj N.S., Patel N., Kalra R. et al. Neurological effects of proprotein convertase subtilisin/kexin type 9
inhibitors: direct comparisons / Eur. Heart J. Qual. Care. Clin.
Outcomes. 2018. Vol. 4, N. 2. P. 132-141.
Bakken M.S., Engeland A., Engesaeter L.B. et al. Increased risk of hip fracture among older people using
antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture
Registry // Age Ageing. 2013. Vol. 42, N. 4. P. 514-520.
Bakken M.S., Engeland A., Engesaeter L.B. et al. Risk of hip fracture among older people using anxiolytic
and hypnotic drugs: a nationwide prospective cohort study // Eur. J. Clin. Pharmacol. 2014. Vol. 70, N. 7.
P. 873-880.
Balamuthusamy S., Srinivasan L., Verma M. et al. Renin angiotensin system blockade and cardiovascular
outcomes in patients with chronic kidney disease and protein-uria: a meta-analysis // Am. Heart J.
2008. Vol. 155, N. 5. P. 791-805.
Bally M., Dendukuri N., Rich B. et al. Risk of acute myocardial infarction with NSAIDs in real world use:
Bayesian meta-analysis of individual patient data // BMJ.
2017. Vol. 357. Article ID j1909.
Balogun R.A., Abdel-Rahman E.M., Balogun S.A. et al. Association of depression and antidepressant use
with mortality in a large cohort of patients with nondialysis-
dependent CKD // Clin. J. Am. Soc. Nephrol. 2012. Vol. 7, N. 11. P. 1793-1800.
Balsells M., García-Patterson A., Sola I. et al. Glibenclamide, metformin, and insulin for the treatment of
gestational diabetes: a systematic review and meta-analy-sis // BMJ. 2015. Vol. 350. Article ID h102.
Bang C.N., Greve A.M., Abdulla J. et al. The preventive effect of statin therapy on new-onset and
recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review
and meta-analysis // Int. J. Cardiol. 2013. Vol. 167,
N. 3. P. 624-630.
Bang C.N., Greve A.M., Kober L. et al. Renin-angiotensin system inhibition is not associated with
increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic
stenosis // Int. J. Cardiol. 2014. Vol. 175, N. 3.
P. 492-498.
Bangalore S., Fakheri R., Toklu B., Messerli F.H. Diabetes mellitus as a compelling indication for use of
renin angiotensin system blockers: systematic review and meta-analysis of randomized trials // BMJ.
2016. Vol. 352. Article ID i438.
Источник KingMed.info
328
Bangalore S., Fakheri R., Wandel S. et al. Renin angiotensin system inhibitors for patients with stable
coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials
// BMJ. 2017. Vol. 356. Article ID J4.
Bangalore S., Fayyad R., Hovingh G.K. et al. Statin and the risk of renal-related
serious adverse events: analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL,
and other placebo-controlled trials // Am. J. Cardiol. 2014. Vol. 113. P. 2018-2020.
Bangalore S., Kumar S., Fusaro M. et al. Outcomes with various drug eluting or bare metal stents in
patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-
up from randomised trials // BMJ. 2012. Vol. 345.
Article ID e5170.
Bangalore S., Schwamm L., Smith E.E. et al. Blood pressure and in-hospital outcomes in patients
presenting with ischaemic stroke // Eur. Heart J. 2017. Vol. 38, N. 37.
P. 2827-2835.
Bangalore S., Schwamm L., Smith E. et al. Relation of Admission Blood Pressure to In-hospital and 90-
Day Outcomes in Patients Presenting With Transient Ischemic
Attack // Am. J. Cardiology. 2019. Vol. 7. P. 1083-1095.
Bansal N. et al. eGFR and albuminuria in relation to risk of incident atrial fibrillation: a meta-analysis of
the Jackson heart study, the multi-ethnic study of atherosclerosis, and the cardiovascular health study
// Clin. J. Am. Soc. Nephrol. 2017. Vol. 12,
N. 9. P. 1386-1398.
Bansal N., Szpiro A., Reynolds K. et al. Long-term outcomes associated with implantable cardioverter
defibrillator in adults with chronic kidney disease // JAMA
Intern. Med. 2018. Vol. 178, N. 3. P. 390-398.
Barber J. Examining the use of tramadol hydrochloride as an antidepressant // Exp. Clin.
Psychopharmacol. 2011. Vol. 19, N. 2. P. 123-130.
Barkas F., Elisaf M., Liberopoulos E. et al. Statin therapy with or without ezetimibe and the progression
to diabetes // J. Clin. Lipidol. 2016. Vol. 10, N. 2. P. 306-313.
Barnard K., Peveler R.C., Holt R.I.G. Antidepressant medication as a risk factor for type 2 diabetes and
impaired glucose regulation: systematic review // Diabetes Care.
2013. Vol. 36, N. 10. P. 3337-3345.
Barnes M., Heywood A.E., Mahimbo A. et al. Acute myocardial infarction and influenza: a meta-analysis
of case-control studies // Heart. 2015. Vol. 101, N. 21.
P. 1738-1747.
Basnet S., Kozikowski A., Makaryus A.N. et al. Metformin and myocardial injury in patients with diabetes
and ST-segment elevation myocardial infarction: a propensity score matched analysis // J. Am. Heart
Assoc. 2015. Vol. 4, N. 10. Article ID e002314.
Источник KingMed.info
329
Bateman B.T., Heide-Jorgensen U., Einarsdóttir K. et al. β-Blocker use in pregnancy and the risk for
congenital malformations: an international cohort study //
Ann. Intern. Med. 2018. Oct. 16. Doi: 10.7326/M18-0338.
Bateman B.T., Hernandez-Diaz S., Fischer M.A. et al. Statins and congenital malformations: cohort study
// BMJ. 2015. Vol. 350. Article ID h1035.
Bathini L., Jandoc R., Kuwornu P. et al. Clinical outcomes of failing to dose-reduce cephalosporin
antibiotics in older adults with CKD // Clin. J. Am. Soc. Nephrol. 2019.
Vol. 2. P. 197-205.
Baumgartner C., da Costa B.R., Collet T.-H. et al. Thyroid function within the normal range, subclinical
hypothyroidism, and the risk of atrial fibrillation //
Circulation. 2017. Vol. 136, N. 22. P. 2100.
Bavishi C., Baber U., Panwar S. et al. Efficacy and safety of everolimus and zotaro-limus-eluting stents
versus first-generation drug-eluting stents in patients with diabetes: a meta-analysis of randomized
trials // Int. J. Cardiol. 2017. Vol. 230. P. 310-318.
Bavishi C., Bangalore S., Messerli F.H. Outcomes of intensive blood pressure lowering in older
hypertensive patients // J. Am. Coll. Cardiol. 2017. Vol. 69, N. 5. P. 486.
Bayliss E.A., Steiner J.F., Fernald D.H. et al. Descriptions of barriers to self-care by persons with
comorbid chronic diseases // Ann. Fam. Med. 2003. Vol. 1, N. 1. P. 15-21.
Bazoukis G., Korantzopoulos P., Tsioufis C. The impact of renal sympathetic denervation on cardiac
electrophysiology and arrhythmias: a systematic review of the
literature // Int. J. Cardiol. 2016. Vol. 220. P. 87-101.
Beach J.M., Mihaljevic T., Svensson L.G. et al. Coronary artery disease and outcomes of aortic valve
replacement for severe aortic stenosis // J. Am. Coll. Cardiol.
2013. Vol. 61, N. 8. P. 837-848.
Beach S.R., Celano C.M., Noseworthy P.A. et al. QTc prolongation, torsades de pointes, and
psychotropic medications // Psychosomatics. 2013. Vol. 54, N. 1. P. 1-13.
Beau A.B., Hurault-Delarue C., Vial T. et al. Safety of oseltamivir during pregnancy: a comparative study
using the EFEMERIS database // BJOG. 2014. Vol. 121, N. 7. P. 895-900.
Behrouz R., Miller C.M. Aspirin and intracerebral hemorrhage: where are we
now? // Neurol. Clin. Pract. 2015. Vol. 5, N. 1. P. 11-16.
Belfort-DeAguiar R.D., Naik S. et al. Inhaled formoterol diminishes insulin-induced hypoglycemia in
type 1 diabetes // Diabetes Care. 2015. Vol. 38. P. 1736-1741.
Berard A., Sheehy O., Girard S. et al. Risk of preterm birth following late pregnancy exposure to NSAIDs
or COX-2 inhibitors // Pain. 2018. Vol. 159, N. 5. P. 948-955.
Berardini A., Biagini E., Saia F. et al. Percutaneous mitral valve repair: the last chance for symptoms
improvement in advanced refractory chronic heart failure? // Int.
J. Cardiol. 2017. Vol. 228. P. 191-197.
Источник KingMed.info
330
Bergenstal R.M., Bailey C.J., Kendall D.M. Type 2 diabetes: assessing the relative risks and benefits of
glucose-lowering medications // Am. J. Med. 2010. Vol. 123, N. 4.
P. 374. e9-e18.
Berger J.S., Sallum R.H., Katona B. et al. Is there an association between aspirin dosing and cardiac and
bleeding events after treatment of acute coronary syndrome? A systematic review of the literature //
Am. Heart J. 2012. Vol. 164, N. 2. P. 153-162.
Bermejo J., Yotti R., García-Orta R. et al. Sildenafil for improving outcomes in patients with corrected
valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized
clinical trial // Eur. Heart J. 2018. Vol. 15.
P. 1255-1264.
Bhutani S., Tobis J., Gevorgyan R. et al. Accuracy of stress myocardial perfusion imaging to diagnose
coronary artery disease in end stage liver disease patients // Am. J.
Cardiol. 2013. Vol. 111, N. 7. P. 1057-1061.
Bickel C., Rupprecht H.J., Blankenberg S. et al. Serum uric acid as an independent predictor of mortality
in patients with angiographically proven coronary artery disease // Am. J. Cardiol. 2002. Vol. 89. P. 12-
17.
Biere-Rafi S., Hutten B.A., Squizzato A. et al. Statin treatment and the risk of
recurrent pulmonary embolism // Eur. Heart J. 2013. Vol. 34, N. 24. P. 1800-1806.
Biffi A., Anderson C.D., Battey T.K. et al. Association between blood pressure control and risk of
recurrent intracerebral hemorrhage // JAMA. 2015. Vol. 314, N 9.
P. 904-912.
Bird S.T., Delaney J.A.C., Brophy J.M. et al. Tamsulosin treatment for benign prostatic hyperplasia and
risk of severe hypotension in men aged 40-85 years in the United States // BMJ. 2013. Vol. 347. Article
ID f6320.
Björnsson E.S., Bergmann O.M., Björnsson H.K. et al. Incidence, presentation, and outcomes in patients
with drug-induced liver injury in the general population of
Iceland // Gastroenterology. 2013. Vol. 144, N. 7. P. 1419-1425.
Blais L., Beauchesne M.F., Lemiere C., Elftouh N. High doses of inhaled cor-ticosteroids during the first
trimester of pregnancy and congenital malformations //
J. Allergy Clin. Immunol. 2009. Vol. 124, N. 6. P. 1229-1234.e4.
Bleske B.E., Clark M.M., Wu A.H. et al. The effect of continuous infusion loop diuretics in patients with
acute decompensated heart failure with hypoalbuminemia //
J. Cardiovasc. Pharmacol. Ther. 2013. Vol. 18, N. 4. P. 334-337.
Blecker S., Agarwal S.K., Chang P.P. et al. Quality of care for heart failure patients hospitalized for any
cause // J. Am. Coll. Cardiol. 2014. Vol. 63, N. 2. P. 123-130.
Boetticher N.C., Peine C.J., Kwo P. et al. A randomized, double-blinded, placebo-controlled multicenter
trial of etanercept in the treatment of alcoholic hepatitis //
Соседние файлы в папке Библиотека им академика М.И. Перельмана